Bioprocesses for Metabolite Production from Marine Invertebrates: The European Horizon BLUES project
Research Ideas and Outcomes · 03.06.2026 · 12
DOI: 10.3897/rio.12.e196757 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Ideas and Outcomes, online erschienen am 03.06.2026. Verfasst von Affif Grazette und 12 weiteren Autor:innen. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
One of the major accomplishments of the 20 th century is the advancement of pharmaceuticals to treat a variety of diseases and metabolic disorders. Traditionally, nature has served as the primary source for new pharmaceuticals, with over 50% of marketed drugs either derived directly from natural sources or synthesised using natural products as templates or starting materials. The ocean is home to more than 200,000 described species of marine invertebrates, representing every phylum, including twelve phyla that are exclusively marine. More than 15,000 novel marine-derived chemicals have been reported, many of which have potential pharmaceutical applications. Many of these compounds occur in marine organisms at very low concentrations and their often complex molecular structures make them difficult to be chemically synthesised, which has created a bottleneck in their development as drugs. Scientists have spent decades, without success, working to develop alternative supply options, including in vitro culturing of marine invertebrates or cell cultures. The objective of BLUES is to expand the potential to produce valuable and unique bioactive compounds from marine invertebrates by developing novel in vitro cell culture systems for four phyla of marine invertebrates (Porifera, Cnidaria, Echinodermata, Chordata) and optimising production yields as an alternative to wild harvesting and chemical synthesis. The goal is to design a pathway towards industrial bioprocesses using cell lines as a chassis to produce unique, high-value, marine bio-based compounds. The novel bioprocesses will solve the supply bottleneck for increased availability of bioactive compounds, but also for a higher level of sustainable alternatives, contributing to the development of circular processing and a circular economy. The BLUES project is supported by the Horizon Europe, European Union research initiative, project number: 101134820.
Zitieren
APA
Grazette, A., Rinkevich, B., Pomponi, S., Atanassova, M., Friðjónsson, Ó., Giovine, M., Pozzolini, M., Labate, G. F. D., Martens, D., Kazbar, A., Silva, T., Thomas, T., & Wijffels, R. (2026). Bioprocesses for Metabolite Production from Marine Invertebrates: The European Horizon BLUES project. Research Ideas and Outcomes, 12. https://doi.org/10.3897/rio.12.e196757
Vancouver
Grazette A, Rinkevich B, Pomponi S, Atanassova M, Friðjónsson Ó, Giovine M, et al. Bioprocesses for Metabolite Production from Marine Invertebrates: The European Horizon BLUES project. Research Ideas and Outcomes. 2026;12. doi:10.3897/rio.12.e196757
BibTeX
@article{Grazette2026,
author = {Grazette, Affif and Rinkevich, Baruch and Pomponi, Shirley and Atanassova, Miroslava and Friðjónsson, Ólafur and Giovine, Marco and Pozzolini, Marina and Labate, Giuseppe Falvo D`Urso and Martens, Dirk and Kazbar, Antoinette and Silva, Tiago and Thomas, Torsten and Wijffels, Rene},
title = {Bioprocesses for Metabolite Production from Marine Invertebrates: The European Horizon BLUES project},
journal = {Research Ideas and Outcomes},
year = {2026},
volume = {12},
doi = {10.3897/rio.12.e196757}
}
EUVIMED